Pharmaceuticals

The pharmaceutical industry is a EUR 1 trillion sector and has been a major engine of economic growth and scientific advancement for decades. The industry encompasses a wide range of enterprises including large ethical drug multi-nationals (so-called Big Pharma), mid-sized specialty pharmaceutical companies, generic manufacturers, virtual pharmas, small biotechnology and biopharmaceutical firms, and all the various ancillary support and service companies that provide contract research, regulatory guidance, contract sales, and manufacturing technologies and raw materials.

Although growth has not been as robust in recent years—mainly due to price pressures, uncertainty in regulatory/reform measures, and weak drug pipelines— the demographic and structural drivers of demand in healthcare still exist: namely, the continued aging of the global population and the increasing sophistication and wealth of developing nations. Shifting epidemiology patterns and outbreaks, along with new challenges in chronic disease, cancer, heart disease, and degenerative disease will continue to impel the need for ever-better medicines. New understanding and technologies in drug delivery, and most especially in the fields of genomics, proteomics, and molecular biology generally, also hold promise for better therapeutics and a revival of profits.
Page 4/16
Category Tools

Applied Biosystems, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Ranbaxy Laboratories Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Moberg Derma AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Cornerstone Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Takeda Pharmaceuticals North America, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Micromet, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Sun Pharmaceutical Industries Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Perrigo Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Evotec AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Labopharm, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Eurand N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Sanofi - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

United Therapeutics Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Hanger, Inc. (formerly Hanger Orthopedic Group, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

MacroGenics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Dr. Reddy's Laboratories, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Cellectis S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

CytRx Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

QRxPharma Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Wright Medical Group, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Profectus BioSciences, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Eli Lilly and Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Nuvo Research, Inc. (formerly Dimethaid Research, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Merck Sharp & Dohme Corp. (formerly Merck & Co., Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

SciClone Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Morphotek, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

CVS Caremark Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

ProMetic Life Sciences, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Actavis Group hf (formerly Pharmaco Hf) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Millipore Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Horizon Discovery, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Centene Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Siemens Healthcare Diagnostics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

454 Life Sciences - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Medtronic, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Proximagen Neuroscience plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Genentech, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Concentra, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Opto Circuits (India), Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Institut National de la Sante et de la Recherche Medicale(INSERM) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Nycomed International Management GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Myriad Genetics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Ligand Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Stiefel Laboratories, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Shire plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Almirall, S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Lupin Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Sonic Healthcare Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Cleveland Biolabs, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Options